干细胞之家 - 中国干细胞行业门户第一站

 

 

搜索
中源协和

免疫细胞治疗专区

欢迎关注干细胞微信公众号

  
查看: 897511|回复: 0
go

[干细胞与细胞生物学类] PDF电子书:Pluripotent Stem Cells ( Laboratory and Clinical Research)   [复制链接]

Rank: 7Rank: 7Rank: 7

积分
1216 
威望
1216  
包包
1952  

金话筒 博览群书 优秀版主

楼主
发表于 2012-4-23 20:58 |显示全部帖子 |倒序浏览 |打印
/ ^& o0 \& U2 w% f0 s3 l
* u8 P& Y; y/ K6 \: E
Product Description: Pluripotent cells of the early embryo originate all types of somatic cells and germ cells of adult organism. Pluripotent stems cell lines were derived from mammalian embryos and adult tissues using different techniques and from different sources. Despite different origin, all pluripotent stem cell lines demonstrate considerable similarity of the major biological properties. This book examines the fundamental mechanisms which regulate normal development of pluripotent cells into different lineages and are disrupted in cancer initiating cells. Analysis gene expression profiles, differentiation potentials and cell cycle of normal and mutant pluripotent stem cells provide new data to search molecular targets to eliminate malignant cells in tumours. In this book, the authors also aim to present a global picture of how extracellular signals, intracellular signal transduction pathways and transcriptional networks co-operate together to determine the cell fate of pluripotent stem cells. Practical, ethical and legal considerations that must be addressed before induced pluripotent stem (iPS) cells can realise their potential in the treatment of degenerative disease is discussed as well. Recent advancements in the cancer stem cell hypothesis are also summarised and the challenges associated with targeting resistant cancers in the context of stem cell microenvironments are presented.
9 E) v. q6 n. X6 H5 ?$ A+ v; }1 E6 ^8 e3 @: `3 K
游客,如果你要查看本帖隐藏内容请回复
附件: 你需要登录才可以下载或查看附件。没有帐号?注册
已有 2 人评分威望 包包 收起 理由
细胞海洋 + 5 + 20 极好资料
tpwang + 6 + 10 极好资料

总评分: 威望 + 11  包包 + 30   查看全部评分

‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册
验证问答 换一个

Archiver|干细胞之家 ( 吉ICP备2021004615号-3 )

GMT+8, 2025-12-16 14:00

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.